Andrew Gengos - 08 Oct 2025 Form 4 Insider Report for Turn Therapeutics Inc. (TTRX)

Reporting relationship: Director
Issuer ticker: TTRX
Reported as of: 08 Oct 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 10 Oct 2025, 09:40:38 UTC
Prior SEC filing: 07 Oct 2025
Next SEC filing: 16 Jan 2026
Source filing: View source filing
Reporting owner signature: /s/ Zuraiz Chaudhary, attorney-in-fact for Andrew Gengos

Key filing fact

Andrew Gengos filed Form 4 for Turn Therapeutics Inc. (TTRX) on 10 Oct 2025.

Key facts

This page summarizes Andrew Gengos's Form 4 filing for Turn Therapeutics Inc. (TTRX).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 10 Oct 2025, 09:40.

Change

Previous filing in this sequence was filed on 07 Oct 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001563623 Primary reporting owner

Gengos Andrew

Relationship: Director
Address: C/O TURN THERAPEUTICS INC., 250 N. WESTLAKE BLVD., WESTLAKE VILLAGE
Signature: /s/ Zuraiz Chaudhary, attorney-in-fact for Andrew Gengos
Signature date: 10 Oct 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

TTRX transaction

Common Stock

Award

Transaction value: $0
Shares: +10,000
Change %
Price: $0.000000
Shares after: 10,000
Date: 08 Oct 2025
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Reflects an award of restricted stock units ("RSUs") granted under the Issuer's 2025 Omnibus Incentive Plan. Each RSU represents a contingent right to receive one share of the Issuer's common stock. These RSUs will vest upon the earlier of the first anniversary of the grant date or a change in control of the Issuer, in each case, subject to the reporting person's continuous service through the vesting date.